Literature DB >> 8639178

Cellular adhesion molecules in rat adjuvant arthritis.

M M Halloran1, Z Szekanecz, N Barquin, G K Haines, A E Koch.   

Abstract

OBJECTIVE: To examine adhesion molecule expression during the progression of inflammation in a rheumatoid arthritis model of adjuvant-induced arthritis (AIA) in rats.
METHODS: Immunohistochemical analysis was used to determine the distribution of the following adhesion molecules: lymphocyte function-associated antigen 1 (LFA-1; CD11a/CD18), Mac-1 and p150/95 (CD11bc/CD18), intercellular adhesion molecule 1 (ICAM-1), and CD44 in tissue sections from the ankle joints of rats with AIA. Control animals and those with AIA were killed at intervals over a 54-day period after injection with mineral oil and Mycobacterium butyricum, respectively.
RESULTS: CD44 and LFA-1 were expressed on lymphocytes, macrophages, and synovial (ST) lining cells. CD44 expression on macrophages was found to be increased compared with control animals by day 18, and was significantly increased by day 41. CD44 expression on lymphocytes significantly increased earlier, on days 11-18. Increased LFA-1 expression on macrophages occurred late, on day 41. LFA-1 expression on lymphocytes was significantly increased on days 25, 47, and 54. ST lining cells exhibited two distinct periods of increased expression, one early, on days 11-25 and one later, on days 41-54. CD11b/c was expressed on macrophages and ST lining cells, showing a significant increase on AIA rat ST lining cells compared with control animals on day 4. No differences in ICAM-1 expression on endothelial cells between rats with AIA and controls were found on any of the days examined.
CONCLUSION: CD44 expression is up-regulated on macrophages and lymphocytes during the early development of AIA, while LFA-1 expression is up-regulated later in the development of AIA. The up-regulation of CD44 and LFA-1 at different times in the development of AIA suggests an important role for these adhesion molecules in establishing and sustaining an inflammatory response in the AIA joint.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8639178     DOI: 10.1002/art.1780390514

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  14 in total

Review 1.  Hyaluronan in immune dysregulation and autoimmune diseases.

Authors:  Nadine Nagy; Hedwich F Kuipers; Payton L Marshall; Esther Wang; Gernot Kaber; Paul L Bollyky
Journal:  Matrix Biol       Date:  2018-04-04       Impact factor: 11.583

2.  Evaluation of the antirheumatic effects of isoflavone-free soy protein isolate and etanercept in rats with adjuvant-induced arthritis.

Authors:  Nahla E El-Ashmawy; Eman G Khedr; Maha M Shamloula; Maha M Kamel
Journal:  Exp Biol Med (Maywood)       Date:  2019-03-21

3.  Amelioration of rat adjuvant-induced arthritis by Met-RANTES.

Authors:  Shiva Shahrara; Amanda E I Proudfoot; James M Woods; Jeffrey H Ruth; M Asif Amin; Christy C Park; Christian S Haas; Richard M Pope; G Kenneth Haines; Yuan Yuan Zha; Alisa E Koch
Journal:  Arthritis Rheum       Date:  2005-06

4.  Initiation and perpetuation of rat adjuvant arthritis is inhibited by the anti-CD2 monoclonal antibody (mAb) OX34.

Authors:  J C Hoffmann; C Herklotz; H Zeidler; B Bayer; H Rosenthal; J Westermann
Journal:  Ann Rheum Dis       Date:  1997-12       Impact factor: 19.103

5.  Imaging of carrageenan-induced local inflammation and adjuvant-induced systemic arthritis with [(11)C]PBR28 PET.

Authors:  Xia Shao; Xueding Wang; Sean J English; Timothy Desmond; Phillip S Sherman; Carole A Quesada; Morand R Piert
Journal:  Nucl Med Biol       Date:  2013-07-25       Impact factor: 2.408

6.  Evening primrose oil and celecoxib inhibited pathological angiogenesis, inflammation, and oxidative stress in adjuvant-induced arthritis: novel role of angiopoietin-1.

Authors:  R M El-Sayed; Y M Moustafa; M F El-Azab
Journal:  Inflammopharmacology       Date:  2014-03-25       Impact factor: 4.473

7.  Immunomodulation of Autoimmune Arthritis by Herbal CAM.

Authors:  Shivaprasad H Venkatesha; Rajesh Rajaiah; Brian M Berman; Kamal D Moudgil
Journal:  Evid Based Complement Alternat Med       Date:  2010-12-22       Impact factor: 2.629

8.  Amelioration of autoimmunity and inflammation by zinc oxide nanoparticles in experimental rheumatoid arthritis.

Authors:  Sameh S Gad; Ahmed M Fayez; Mahmoud Abdelaziz; Doaa Abou El-Ezz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-07-08       Impact factor: 3.000

9.  Characterization and treatment monitoring of inflammatory arthritis by photoacoustic imaging: a study on adjuvant-induced arthritis rat model.

Authors:  Justin R Rajian; Xia Shao; David L Chamberland; Xueding Wang
Journal:  Biomed Opt Express       Date:  2013-05-17       Impact factor: 3.732

Review 10.  CD44 in rheumatoid arthritis.

Authors:  David Naor; Shlomo Nedvetzki
Journal:  Arthritis Res Ther       Date:  2003-02-28       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.